Logo

American Heart Association

  2
  0


Final ID: Mo4124

Intramyocardial Hydrogel Injections in Porcine Model of Infarction Remodeling Demonstrates Improved Left Ventricular Performance on Pressure-Volume Analysis Associated with Decreased Matrix Metalloproteinase Activation

Abstract Body (Do not enter title and authors here): Introduction: Following myocardial infarction (MI), extracellular matrix (ECM) degradation significantly contributes to adverse left ventricular (LV) remodeling mediated by the activation of matrix metalloproteinases (MMPs). Intramyocardial injection of hydrogels that locally release MMP inhibitors are designed to modulate MMP activation, increase wall thickness, reducing wall stress, resulting in improved regional mechanics and function. Pressure-volume (PV) analysis is an established approach for evaluation of cardiac performance.

Methods: Chronic reperfused MI was created by a 90-min LAD occlusion in swine (n=16). PV loop analysis was performed using simultaneous 3D echocardiography and invasive LV pressures at baseline and 5 weeks post-MI. Therapeutic hydrogels were delivered by direct intramyocardial injection (9x100 μl) at 7 days post-MI using hyaluronic acid hydrogels alone (HA-Only) (n=4) or hyaluronic acid that releases an MMP inhibitor doxycycline (HA-DOX) (n=5) into the MI region. Outcomes were compared to control MI pigs (n=7) at 5 weeks post-MI to assess therapeutic benefits. MMP inhibition was measured by uptake of the SPECT MMP targeted radiotracer, 99mTc-RP805 in the infarct region.

Results: Quantitative indices of remodeling from representative PV loops are shown in Figure 1 A-C. LV end-diastolic volume (LVEDV) corrected for body weight (BW) was significantly greater in the MI-controls at 5 weeks post-MI compared to the HA-DOX group (Fig 1D, p=0.035, t-test). There was a statistically significant difference in LV end-diastolic pressure (LVEDP) (Fig 1E) between MI-controls and HA-DOX (p=0.025, ANOVA). There was a trend for decreased LV compliance (Fig 1F) in MI-controls based on the EDPVR V30. These changes correlated with a significant decrease in 99mTc-RP805 in the MI region of HA-DOX animals compared to controls (Fig 1G).

Conclusion: LV PV analysis demonstrated significant adverse remodeling in control pigs that was reduced by early intramyocardial delivery of a DOX releasing hydrogel post-MI. Delivery of both hydrogels prevented some measures of adverse LV remodeling, with prevention of LV dilatation and reduction in LVEDP and correlated with a decrease in MMP activation by SPECT 99mTc-RP805.
  • Porcaro, Olivia  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Spinale, Francis  ( USC SCHOOL MEDICINE , Columbia , South Carolina , United States )
  • Duncan, James S  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Heerdt, Paul  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Burdick, Jason  ( UNIVERSITY OF COLORADO , Boulder , Colorado , United States )
  • Sinusas, Albert  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Thorn, Stephanie  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Ahn, Shawn  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Lee, Supum  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Uman, Selen  ( University of Pennsylvania , San Francisco , Pennsylvania , United States )
  • Lysyy, Taras  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Burns, Rachel  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Guerrera, Nicole  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Vermillion, Billy  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Author Disclosures:
    Olivia Porcaro: DO NOT have relevant financial relationships | Francis Spinale: No Answer | James S Duncan: DO NOT have relevant financial relationships | Paul Heerdt: DO have relevant financial relationships ; Consultant:Cardiage LLC:Active (exists now) ; Individual Stocks/Stock Options:emka Medical:Expected (by end of conference) ; Research Funding (PI or named investigator):Edwards Lifesciences:Past (completed) ; Consultant:Edwards Lifesciences:Past (completed) ; Consultant:Fire1 Foundry:Past (completed) ; Consultant:Baudax Bio:Past (completed) | Jason Burdick: No Answer | Albert Sinusas: DO have relevant financial relationships ; Research Funding (PI or named investigator):Siemens:Active (exists now) ; Research Funding (PI or named investigator):RevaliaBio:Active (exists now) ; Consultant:MostCardio, LLC:Active (exists now) ; Consultant:MicroVide, LLC:Active (exists now) ; Research Funding (PI or named investigator):Jubilant:Active (exists now) | Stephanie Thorn: DO NOT have relevant financial relationships | Shawn Ahn: No Answer | Supum Lee: No Answer | Selen Uman: No Answer | Taras Lysyy: No Answer | Rachel Burns: DO NOT have relevant financial relationships | nicole guerrera: DO NOT have relevant financial relationships | Billy Vermillion: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Novel Applications of Imaging in Emerging Clinical Applications

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts from these authors:
High Throughput 3D-Printed Human Engineered Heart Tissues for Cardiac Disease Modeling

Juarros Miranda, Dhand Abhishek, Martin Thomas, Valle-ayala Henry, Hunt Dakota, Burdick Jason, Leinwand Leslie

Systemic Heparin Administration Does Not Inhibit microRNA Amplification in Patients with Myocardial Infarction

Barringhaus Kurt, Slone Sarah, Prousi George, Samani Stephanie, Freeburg Lisa, Churillo Amelia, Spinale Francis

You have to be authorized to contact abstract author. Please, Login
Not Available